Cargando…
Efficacy and Safety Outcomes of Intravitreal Dexamethasone Implant Therapy for the Treatment of Adult Coats' Disease
PURPOSE: To evaluate the efficacy and safety outcomes of dexamethasone intravitreal implant in patients with Stage 3A Coats' disease. METHODS: A consecutive case series of adult Coats' disease managed with or without intravitreal dexamethasone implant (Ozurdex®, Allergan Inc., Irvine, Cali...
Autores principales: | Chen, Qingshan, Liang, Saying, Wang, Xizhen, Hu, Chenli, She, Jieting, Li, Zi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547358/ https://www.ncbi.nlm.nih.gov/pubmed/33062317 http://dx.doi.org/10.1155/2020/9131908 |
Ejemplares similares
-
Intravitreal Dexamethasone Implant (Ozurdex) in Coats’ Disease
por: Saatci, Ali Osman, et al.
Publicado: (2013) -
Refractory adult Coats disease treated with dexamethasone intravitreal implant: A case report
por: Ding, Yu-hua, et al.
Publicado: (2020) -
Efficacy and Safety of Intravitreal Dexamethasone Implants for Treatment of Refractory Diabetic Macular Edema
por: Unsal, Erkan, et al.
Publicado: (2017) -
Adult Coats’ Disease Successfully Managed with the Dexamethasone Intravitreal Implant (Ozurdex®) Combined with Retinal Photocoagulation
por: Martínez-Castillo, Sebastián, et al.
Publicado: (2012) -
Efficacy and Safety of Combined Vitrectomy with Intravitreal Dexamethasone Implant for Advanced Stage Epiretinal Membrane
por: Iovino, Claudio, et al.
Publicado: (2019)